Related Experiment Video
Updated: May 15, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Staphylococcus aureus and Chronic Airway Disease
Lara Derycke1, Claudina Pérez-Novo, Koen Van Crombruggen
1From the Upper Airway Research Laboratory (URL), Department of Oto-Rhino-Laryngology, Ghent University Hospital, Ghent University, Belgium; and *Centre Hospitalier Universitaire de Québec, Pavillon Saint-François d'Assise, Québec, Canada.
Staphylococcus aureus (S. aureus) drives severe upper airway inflammation, like chronic rhinosinusitis with nasal polyps. Understanding S. aureus
Area of Science:
- Immunology
- Otolaryngology
- Microbiology
Background:
- Staphylococcus aureus (S. aureus) is linked to persistent, severe upper airway inflammation.
- Conditions like chronic rhinosinusitis with nasal polyps exhibit T-helper 2-driven inflammation, marked by elevated interleukin-5 and local immunoglobulin E production.
Purpose of the Study:
- To investigate the role of S. aureus and its enterotoxins in deregulating upper airway tissue inflammation.
- To identify triggers of pathomechanisms contributing to chronic inflammatory processes in the upper airways.
Main Methods:
- The study focuses on analyzing the molecular and cellular interactions between S. aureus, its enterotoxins, and host tissues.
- Investigates the impact on structural cells and both innate and adaptive immune responses.
Main Results:
- S. aureus and its enterotoxins were found to disrupt normal tissue homeostasis.
- These bacteria and toxins influence inflammation at multiple levels, affecting cellular and immune systems.
Conclusions:
- S. aureus significantly contributes to the pathogenesis of chronic upper airway inflammatory diseases.
- Elucidating these pathomechanisms is crucial for developing targeted therapeutic strategies against S. aureus-associated inflammation.
More Related Videos
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Microbiota of the Respiratory Tract
Staphylococcal Skin Infections
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...